FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma
Open Access
- 11 August 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (51) , 84375-84387
Abstract
FOXC1 promotes melanoma by activating MST1R/PI3K/AKTKeywords
This publication has 42 references indexed in Scilit:
- Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationBMC Cancer, 2016
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous MelanomaJournal of Investigative Dermatology, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Automated Tracking of Nanoparticle-labeled Melanoma Cells Improves the Predictive Power of a Brain Metastasis ModelCancer Research, 2013
- High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patientsTumor Biology, 2012
- Overexpression of Forkhead Box C1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular CarcinomaHepatology, 2012
- β-Catenin is required for Ron receptor-induced mammary tumorigenesisOncogene, 2011
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer BiomarkersJournal of Clinical Oncology, 2008
- The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cellsOncogene, 2008
- The emerging roles of forkhead box (Fox) proteins in cancerNature Reviews Cancer, 2007